A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Clinical trial NCT06868199 · RECRUITING
Trial details
- NCT number
- NCT06868199
- Sponsor
- LaNova Medicines Limited
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-06
- Primary completion
- 2027-08-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.